SALUS, Ljubljana, d. d. Reports Earnings Results for the Half Year Ended June 30, 2022
August 11, 2022
Share
SALUS, Ljubljana, d. d. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 247.39 million compared to EUR 217.49 million a year ago. Net income was EUR 6.43 million compared to EUR 7.39 million a year ago.
Basic earnings per share from continuing operations was EUR 61.57 compared to EUR 70.82 a year ago.
Salus Ljubljana dd is a Slovenia-based company engaged in the wholesale and distribution of medical products. The Company's portfolio includes pharmaceuticals, medical devices, medical supplies, food supplements, cosmetic products and other health products. The Company's core clients are pharmacies, hospitals and health centers from both Slovenia and abroad. Moreover, Salus Ljubljana dd offers the products to its business partners through the Internet store. The Company also provides additional services related to the registration of medicines and the distribution and storage of pharmaceuticals and other medical products.